Carmell (CTCX) Competitors $0.44 -0.02 (-3.30%) Closing price 01/23/2025 04:00 PM EasternExtended Trading$0.44 0.00 (-0.68%) As of 08:51 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CTCX vs. NXL, MODD, OM, DXR, MDAI, MBOT, NMTC, SURG, POCI, and XAIRShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include Nexalin Technology (NXL), Modular Medical (MODD), Outset Medical (OM), Daxor (DXR), Spectral AI (MDAI), Microbot Medical (MBOT), NeuroOne Medical Technologies (NMTC), SurgePays (SURG), Precision Optics (POCI), and Beyond Air (XAIR). These companies are all part of the "medical equipment" industry. Carmell vs. Nexalin Technology Modular Medical Outset Medical Daxor Spectral AI Microbot Medical NeuroOne Medical Technologies SurgePays Precision Optics Beyond Air Carmell (NASDAQ:CTCX) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability. Do institutionals and insiders believe in CTCX or NXL? 24.2% of Carmell shares are held by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are held by institutional investors. 29.0% of Carmell shares are held by insiders. Comparatively, 24.0% of Nexalin Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, CTCX or NXL? Carmell has a beta of 0.3, suggesting that its share price is 70% less volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 4.24, suggesting that its share price is 324% more volatile than the S&P 500. Does the media favor CTCX or NXL? In the previous week, Nexalin Technology had 2 more articles in the media than Carmell. MarketBeat recorded 2 mentions for Nexalin Technology and 0 mentions for Carmell. Nexalin Technology's average media sentiment score of 0.75 beat Carmell's score of 0.00 indicating that Nexalin Technology is being referred to more favorably in the news media. Company Overall Sentiment Carmell Neutral Nexalin Technology Positive Does the MarketBeat Community favor CTCX or NXL? Nexalin Technology received 1 more outperform votes than Carmell when rated by MarketBeat users. CompanyUnderperformOutperformCarmellN/AN/ANexalin TechnologyOutperform Votes150.00% Underperform Votes150.00% Do analysts rate CTCX or NXL? Nexalin Technology has a consensus target price of $3.00, indicating a potential upside of 15.38%. Given Nexalin Technology's stronger consensus rating and higher possible upside, analysts plainly believe Nexalin Technology is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nexalin Technology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is CTCX or NXL more profitable? Carmell has a net margin of 0.00% compared to Nexalin Technology's net margin of -3,407.98%. Nexalin Technology's return on equity of -187.59% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets CarmellN/A -217.50% -50.22% Nexalin Technology -3,407.98%-187.59%-167.21% Which has preferable earnings & valuation, CTCX or NXL? Nexalin Technology has higher revenue and earnings than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCarmellN/AN/A-$15.44MN/AN/ANexalin Technology$110K314.36-$4.65M-$0.64-4.06 SummaryNexalin Technology beats Carmell on 9 of the 13 factors compared between the two stocks. Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.20M$4.91B$5.44B$9.26BDividend YieldN/A52.56%5.36%3.98%P/E RatioN/A14.7161.6413.90Price / SalesN/A56.921,282.3576.67Price / CashN/A52.1044.4137.65Price / Book0.418.135.054.74Net Income-$15.44M$13.87M$117.90M$224.54M7 Day Performance-16.22%1.72%2.63%1.24%1 Month Performance54.55%9.72%3.68%3.17%1 Year Performance-86.34%34.16%27.48%22.74% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmell0.3866 of 5 stars$0.44-3.3%N/A-85.8%$9.20MN/A0.0014Gap DownNXLNexalin Technology2.3924 of 5 stars$3.16flat$3.00-5.1%+600.8%$42.03M$110,000.00-4.943News CoverageMODDModular Medical2.3468 of 5 stars$1.21-0.8%$5.00+313.2%-33.2%$41.98MN/A-1.9220Gap UpOMOutset Medical2.964 of 5 stars$0.79-3.4%$4.50+469.6%-77.1%$41.51M$130.38M-0.29520Gap DownDXRDaxor3.0512 of 5 stars$8.50+5.1%$24.75+191.2%-12.1%$41.14MN/A0.0037Negative NewsMDAISpectral AI2.1957 of 5 stars$1.96-5.8%$4.50+129.6%-16.2%$36.44M$18.06M-3.0283News CoverageNegative NewsMBOTMicrobot Medical2.4374 of 5 stars$1.64-7.9%$7.00+326.8%+48.1%$33.19MN/A-2.0520Gap UpNMTCNeuroOne Medical TechnologiesN/A$1.05+1.0%N/A-17.0%$32.38M$3.45M-2.2820SURGSurgePays3.0823 of 5 stars$1.55-1.9%$8.50+448.4%-75.7%$31.25M$137.14M-1.3740POCIPrecision Optics0.5034 of 5 stars$4.89flatN/A-15.7%$31.05M$19.10M-7.8980XAIRBeyond Air4.4239 of 5 stars$0.42+11.6%$3.67+778.2%-70.8%$30.14M$1.16M-0.3070News CoverageGap Up Related Companies and Tools Related Companies NXL Alternatives MODD Alternatives OM Alternatives DXR Alternatives MDAI Alternatives MBOT Alternatives NMTC Alternatives SURG Alternatives POCI Alternatives XAIR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CTCX) was last updated on 1/24/2025 by MarketBeat.com Staff From Our PartnersVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredJUST RELEASED: HUGE NEW A.I. TRADEI’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.